Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04420962 · ClinicalTrials.gov registry record
Automated Quantitative Ulcer Analysis Study
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 124
- Enrollment target
NCT04420962: Completed study, sponsored by University of Michigan.
NCT04420962 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 124 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04420962 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 124 participants
- Enrollment target
Study Summary
This is a multiple site observational study that will review patient features (clinical and morphologic) over a 90 day period during care of participants with microbial keratitis with presence of clinically significant ≥2mm stromal infiltrate compared with participants with other forms of keratitis.
Primary Outcome
Visual Acuity
Interventions
- DIAGNOSTIC_TEST Visual Acuity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2020-07-23 |
| Est. Completion | 2024-06-07 |
What the finished NCT04420962 record still lists
NCT04420962 is an observational study that tracks outcomes without assigning an intervention. The registered 124 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Visual Acuity is the first listed.
NCT04420962 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04420962 about?
NCT04420962 is a clinical study titled "Automated Quantitative Ulcer Analysis Study". This is a multiple site observational study that will review patient features (clinical and morphologic) over a 90 day period during care of participants with microbial keratitis with presence of clinically significant ≥2mm stromal infiltrate compared with participants with other forms of keratitis.
What is the current status of trial NCT04420962?
This trial is currently completed. The enrollment target is 124 participants. The study started on 2020-07-23. Estimated completion is 2024-06-07.
What interventions are being tested in trial NCT04420962?
The interventions under investigation include: Visual Acuity (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04420962?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523014 · 124 participants · Phase 2
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- NCT02670707 · 124 participants · Phase 3
Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
- NCT02830724 · 124 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
- NCT04748809 · 124 participants · NA
Effect of Anti-inflammatory Diet in Rheumatoid Arthritis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI